Literature DB >> 30315677

TNM clinical staging of prostate cancer: issues and solutions.

Murali Varma1, Dennis Cochlin2, Brett Delahunt3, Howard Kynaston4, John Rees2, Brian Rous5, Krishna Narahari4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30315677     DOI： 10.1111/bju.14589

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  3 in total

1.  Development and Validation of Nomograms to Predict Cancer-Specific Survival and Overall Survival in Elderly Patients With Prostate Cancer: A Population-Based Study.

Authors:  Zhaoxia Zhang; Chenghao Zhanghuang; Jinkui Wang; Xiaomao Tian; Xin Wu; Maoxian Li; Tao Mi; Jiayan Liu; Liming Jin; Mujie Li; Dawei He
Journal:  Front Oncol       Date:  2022-06-23       Impact factor: 5.738

2.  Identification of the Key Genes Involved in the Tumorigenesis and Prognosis of Prostate Cancer.

Authors:  Wenxuan Wang; Qinghui Wu; Ali Mohyeddin; Yousheng Liu; Zhitao Liu; Jianqiang Ge; Bao Zhang; Gan Shi; Weifu Wang; Dinglan Wu; Fei Wang
Journal:  Comput Math Methods Med       Date:  2022-10-05       Impact factor: 2.809

Review 3.  Incorporating Prognostic Biomarkers into Risk Assessment Models and TNM Staging for Prostate Cancer.

Authors:  Ragheed Saoud; Nassib Abou Heidar; Alessia Cimadamore; Gladell P Paner
Journal:  Cells       Date:  2020-09-17       Impact factor: 6.600
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.